Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 122,258 shares at $13.22 ($1.6M) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Scheduled sale ($1.6M) by COO & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.22 | 60,929 | $805K | 49.8% |
| 2 | $13.22 | 60,929 | $805K | 49.8% |
| 3 | $13.61 | 400 | $5K | 0.3% |
| Total | $13.22 avg | 122,258 | $1.6M | 100% |
| Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |
| STOK | SELL | 2021-12-03 | $139K | — | Filing → |